PRESENTATION TITLE
Bladder Cancer:  Advances in Therapy and Understanding of Tumor Biology

PRESENTER(S)
Guru P. Sonpavde, M.D.
Bladder Cancer Director, Dana-Farber Cancer Institute | Associate Professor of Medicine, Harvard Medical School | Dana-Farber Cancer Institute, Boston, MA

PRESENTER BIO

Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.

VIEWING LOCATIONS
Zoom Registration Link
LEARNING OBJECTIVES

• Demonstrate knowledge of current therapy of urothelial carcinoma.
• Assess information regarding emerging knowledge of tumor biology.
• Apply knowledge of biology to the clinical care of urothelial carcinoma patients.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.